The FDA issued an emergency use authorization (EUA) for PAXLOVID (nirmatrelvir co-packaged with ritonavir) for the treatment of mild-to-moderate COVID-19 in certain adults and pediatric patients at high risk for progression to severe COVID-19, including hospitalization or death. On July 6, the FDA revised the EUA to let pharmacists prescribe and dispense PAXLOVID to eligible patients without seeing a doctor […]

On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the 2023 Medicare physician payment schedule. While American Medical Association (AMA) staff will analyze and develop a summary of the 2,000+ page proposal, they wanted to make physicians aware of three key issues. Notably, the 2023 Medicare conversion […]

Violence against children, nurses, doctors, healthcare workers, or any individual in our workplaces, our communities, our houses of worship, and most certainly our schools, cannot be tolerated. The MSV is appalled at the recent attacks in Buffalo, Uvalde, and Tulsa. Gun violence is unacceptable and something must be done to address it. MSV stands in […]